Bio­gen leaps in­to a show­down be­tween Roche and Re­gen­eron, bet­ting on a po­ten­tial new fran­chise play­er

Plagued by a woe­ful launch for its Alzheimer’s fran­chise, Bio­gen is bet­ting $30 mil­lion on some re­li­able part­ners at Genen­tech to come up with a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.